Health & Nutrition
Mabimmune aims to develop immunotherapeutics with best-in-class therapeutic indices to treat patients with solid tumors.
Home
Thank you for subscribing!
You may opt out any time. For further information consult our Privacy Policy.
Pfingstweidstrasse 3
CH-8005 Zurich
office@venture.ch
+41 (0) 43 366 99 22
Cookie notice | Imprint | Privacy policy | General conditions